Medwing, a European startup building a job market for healthcare professionals, has raised €44 million ($47 million) in Series C funding.
Founded in Berlin in 2017, Medwing targets the healthcare industry in Germany and the UK with a platform designed to match hospitals and clinics with nurses and elderly caregivers, but also pharmacists. , midwives, doctors, and similar professionals.
The platform is now available in Germany and the UK, giving nearly 5,500 registered healthcare employers and 500,000 healthcare professionals access to fully digital workflows spanning job applications, contracts, signatures and timesheets. I claim that I can.
“The current market for permanent recruitment and placement in healthcare is broken and still very manual and analog. It also improves service levels for workers and hospitals.”
Medwing platform
healthy sector
A quick look at the competitive landscape reveals many similar players, especially in the US, where companies like ShiftMed recently raised $200 million. Nomad Health secured him $105 million. Incredible Health got him $80 million. Vivian Health he raised $60 million.
Meanwhile, in Europe, UK-based Florence raised $35 million last year, and France’s Hublot raised VC funding with a similar marketplace concept.
Medwing has said it seeks to differentiate itself from other players with an emphasis on both permanent and temporary placements. In addition, he works directly with major healthcare his clients, such as the Berlin-based university hospital Charité, while also supporting traditional recruitment agencies looking to market their own temporary staff on their platform. increase.
Roggendorf says:
To date, Medwing has raised around €43 million in several rounds.With an additional $47 million in the bank, the company says it hopes to expand further into European markets in the near future, but is likely to do so by the end of this year based solely on its existing presence in Germany and the UK. We expect to reach profitability in 2020.
“For now, we are focusing on these two countries, but we plan to expand to other European countries and become the leading market for medical jobs in Europe,” said Roggendorf. increase. “But ultimately, this is the global problem we’re trying to solve.”
Medwing’s Series C round included funding from Northzone, Cathay Innovation, Cherry Ventures, Quadrille Capital, Atlantic Labs and Hambro Perks. It also included his SVB Capital, his VC entity at SVB, somewhat interestingly given last week’s Silicon Valley Bank (SVB) debacle. .
SVB Capital is not directly affected by the bankruptcy, but the parent company of the SVB Financial holding company it shares with appears to be proceeding with the sale of assets, including SVB Capital. However, none of that is said to have affected his cash spending on Medwing.
